Ratings by H.C. Wainwright (Brandon Folkes)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/24/2026 | MannKind | MNKD | Maintain | Buy (Buy) |
|
Details | ||
| 7/22/2026 | PolyPid Ltd. | PYPD | Maintain | Buy (Buy) |
|
Details | ||
| 7/20/2026 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2026 | Cardiol Therapeutics | CRDL | Maintain | Buy (Buy) |
|
Details | ||
| 6/29/2026 | Omeros Corp. | OMER | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2026 | Connect Biopharma Holdings Ltd | CNTB | Maintain | Buy (Buy) |
|
Details | ||
| 6/24/2026 | Zevra Therapeutics, Inc. | ZVRA | Maintain | Buy (Buy) |
|
Details | ||
| 6/23/2026 | Enanta Pharmaceuticals | ENTA | Maintain | Buy (Buy) |
|
Details | ||
| 6/23/2026 | Achieve Life Sciences | ACHV | Maintain | Buy (Buy) |
|
Details | ||
| 6/18/2026 | Traws Pharma Inc. | TRAW | Downgrade | Neutral (Buy) |
0.02 (0.49) |
2350% | Details | |
| 6/18/2026 | Connect Biopharma Holdings Ltd | CNTB | Maintain | Buy (Buy) |
|
Details | ||
| 6/10/2026 | Omeros Corp. | OMER | Maintain | Buy (Buy) |
|
Details | ||
| 6/9/2026 | Zevra Therapeutics, Inc. | ZVRA | Maintain | Buy (Buy) |
|
Details | ||
| 6/5/2026 | Talphera | TLPH | New Coverage | Buy (N/A) |
0.80 (1.35) |
68.75% | Details | |
| 6/3/2026 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2026 | Rein Therapeutics | RNTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2026 | SINTX Tech | SINT | Maintain | Buy (Buy) |
|
Details | ||
| 5/20/2026 | Traws Pharma Inc. | TRAW | Maintain | Buy (Buy) |
|
Details | ||
| 5/12/2026 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2026 | MannKind | MNKD | Maintain | Buy (N/A) |
|
Details | ||
| 4/28/2026 | CorMedix | CRMD | Maintain | Buy (Buy) |
|
Details | ||
| 4/22/2026 | Eupraxia Pharmaceuticals | EPRX | Maintain | Buy (Buy) |
|
Details | ||
| 4/16/2026 | Achieve Life Sciences | ACHV | Maintain | Buy (Buy) |
|
Details | ||
| 4/13/2026 | SINTX Tech | SINT | New Coverage | Buy (N/A) |
2.68 (1.40) |
-47.76% | Details | |
| 3/26/2026 | Journey Medical Corp. | DERM | Maintain | Buy (Buy) |
|
Details | ||
| 3/25/2026 | Achieve Life Sciences | ACHV | Maintain | Buy (Buy) |
|
Details | ||
| 3/17/2026 | Eupraxia Pharmaceuticals | EPRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2026 | MannKind | MNKD | Maintain | Buy (N/A) |
|
Details | ||
| 1/23/2026 | CorMedix | CRMD | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2026 | Indivior | INDV | Maintain | Buy (N/A) |
|
Details | ||
| 12/30/2025 | Zevra Therapeutics, Inc. | ZVRA | Maintain | Buy (Buy) |
|
Details | ||
| 12/15/2025 | Milestone Pharmaceuticals | MIST | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2025 | Cardiol Therapeutics | CRDL | Maintain | Buy (Buy) |
|
Details | ||
| 11/13/2025 | CorMedix | CRMD | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2025 | Collegium Pharmaceutical | COLL | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2025 | Indivior | INDV | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2025 | Rani Therapeutics Holdsing s | RANI | New Coverage | Buy (N/A) |
2.25 (0.85) |
-62.22% | Details | |
| 10/17/2025 | Achieve Life Sciences | ACHV | Maintain | Buy (Buy) |
|
Details | ||
| 10/16/2025 | Omeros Corp. | OMER | Maintain | Buy (N/A) |
|
Details | ||
| 10/2/2025 | Eupraxia Pharmaceuticals | EPRX | Maintain | Buy (Buy) |
|
Details | ||
| 9/30/2025 | Connect Biopharma Holdings Ltd | CNTB | Maintain | Buy (Buy) |
|
Details | ||
| 9/30/2025 | Enanta Pharmaceuticals | ENTA | Maintain | Buy (Buy) |
|
Details | ||
| 9/23/2025 | Rein Therapeutics | RNTX | Maintain | Buy (Buy) |
|
Details | ||
| 9/23/2025 | Achieve Life Sciences | ACHV | Maintain | Buy (Buy) |
|
Details | ||
| 9/22/2025 | Rein Therapeutics | RNTX | New Coverage | Buy (N/A) |
1.21 (0.79) |
-34.71% | Details | |
| 9/3/2025 | MannKind | MNKD | Maintain | Buy (N/A) |
|
Details | ||
| 8/25/2025 | Journey Medical Corp. | DERM | New Coverage | Buy (N/A) |
7.47 (6.19) |
-17.14% | Details | |
| 8/21/2025 | Achieve Life Sciences | ACHV | New Coverage | Buy (N/A) |
2.58 (6.10) |
136.43% | Details | |
| 8/20/2025 | Eupraxia Pharmaceuticals | EPRX | Maintain | Buy (Buy) |
|
Details | ||
| 8/19/2025 | Valneva SE | VALN | New Coverage | Buy (N/A) |
12.14 (4.78) |
-60.63% | Details | |
| 8/19/2025 | Genfit | GNFT | New Coverage | Buy (N/A) |
4.50 (4.85) |
7.78% | Details | |
| 8/12/2025 | Xeris Pharmaceuticals | XERS | New Coverage | Buy (N/A) |
7.20 (8.32) |
15.56% | Details | |
| 8/11/2025 | ANI Pharmaceuticals | ANIP | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2025 | Collegium Pharmaceutical | COLL | New Coverage | Buy (N/A) |
34.93 (35.20) |
0.77% | Details | |
| 8/8/2025 | ANI Pharmaceuticals | ANIP | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | CorMedix | CRMD | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2025 | Sagimet Biosciences Inc | SGMT | New Coverage | Buy (N/A) |
9.17 (7.07) |
-22.9% | Details | |
| 8/6/2025 | Indivior | INDV | New Coverage | Buy (N/A) |
21.80 (40.53) |
85.92% | Details | |
| 7/28/2025 | Enanta Pharmaceuticals | ENTA | New Coverage | Buy (Buy) |
7.40 (12.78) |
72.7% | Details | |
| 7/24/2025 | ANI Pharmaceuticals | ANIP | Maintain | Buy (Buy) |
|
Details | ||
| 7/23/2025 | Cardiol Therapeutics | CRDL | Maintain | Buy (Buy) |
|
Details | ||
| 7/16/2025 | MannKind | MNKD | New Coverage | Buy (N/A) |
3.85 (4.13) |
7.27% | Details | |
| 7/10/2025 | ANI Pharmaceuticals | ANIP | New Coverage | Buy (N/A) |
65.31 (77.65) |
18.89% | Details | |
| 7/2/2025 | Zevra Therapeutics, Inc. | ZVRA | New Coverage | Buy (N/A) |
8.95 (9.53) |
6.48% | Details | |
| 6/30/2025 | Omeros Corp. | OMER | Maintain | Buy (Buy) |
|
Details | ||
| 6/30/2025 | CorMedix | CRMD | New Coverage | Buy (N/A) |
12.50 (7.87) |
-37.04% | Details | |
| 6/26/2025 | Eupraxia Pharmaceuticals | EPRX | New Coverage | Buy (N/A) |
4.31 (5.81) |
34.8% | Details | |
| 6/17/2025 | Milestone Pharmaceuticals | MIST | Maintain | Buy (Buy) |
|
Details | ||
| 6/12/2025 | Connect Biopharma Holdings Ltd | CNTB | New Coverage | Buy (N/A) |
0.82 (2.14) |
160.98% | Details | |
| 6/10/2025 | PolyPid Ltd. | PYPD | Maintain | Buy (N/A) |
|
Details | ||
| 6/10/2025 | Omeros Corp. | OMER | New Coverage | Buy (N/A) |
3.77 (9.79) |
159.68% | Details | |
| 6/5/2025 | Milestone Pharmaceuticals | MIST | New Coverage | Buy (N/A) |
1.65 (1.16) |
-29.7% | Details | |
| 6/3/2025 | Trevi Therapeutics | TRVI | Maintain | Buy (Buy) |
|
Details | ||
| 6/2/2025 | PolyPid Ltd. | PYPD | New Coverage | Buy (N/A) |
2.80 (3.90) |
39.29% | Details | |
| 6/2/2025 | Cardiol Therapeutics | CRDL | New Coverage | Buy (N/A) |
1.25 (1.18) |
-5.6% | Details | |
| 5/28/2025 | Trevi Therapeutics | TRVI | New Coverage | Buy (N/A) |
6.16 (17.54) |
184.74% | Details |
